随访对慢性肢体威胁性缺血患者死亡率的影响
本研究纳入2019至2023年因腹股沟下慢性肢体威胁性缺血(CLTI)住院且出院后存活至少30天的患者,按1年内是否完成任何血管门诊随访分层,评估随访依从性与1年死亡率的关系及不依从的危险因素。结果显示不依从与1年死亡率升高相关(40.9% vs 15.6%,OR 6.67,P=0.005),转院来源和缺乏初级保健提供者是不依从的危险因素。
要点
- 不依从血管随访与1年死亡率升高相关(40.9% vs 15.6%,OR 6.67,P=0.005)。
- 转院来源患者随访不依从比例更高(30.2% vs 10.2%,OR 3.704,P=0.014)。
- 缺乏初级保健提供者与随访不依从强相关(66.7% vs 11.8%,OR 14.603,P<0.001)。
核心结论
- 不依从血管随访与CLTI患者1年死亡率升高相关。
- 作者认为改善CLTI患者在门诊环境中转诊至血管外科医生(先于需要紧急院际转院)以及通过初级保健提供者进行照护协调,可能有助于提高血管随访依从性。
研究设计与样本
- 纳入2019至2023年因腹股沟下CLTI住院且出院后存活至少30天的所有患者,共131例,中位年龄73岁。
- 按1年内是否完成任何门诊血管随访(定义为指数住院后针对指数肢体CLTI的任何门诊就诊)分层。
- 主要终点为1年死亡率,并评估随访不依从的危险因素;多变量模型校正年龄、临床合并症、药物治疗及解剖/临床肢体严重程度等。
- 采用多种随访依从性定义进行额外敏感性分析以增强结果可靠性。
主要发现
- 97例(74.1%)存在组织缺损,118例(90.1%)接受指数血运重建,13例(9.9%)因不可挽救病变或患者偏好未接受干预。
- 总体1年死亡率为19.8%,随访依从率为83.2%。
- 不依从血管随访与更高的1年死亡率相关(40.9% vs 15.6%,OR 6.67,P=0.005),该发现在测试所有随访定义时均持续存在。
- 随访不依从的危险因素包括从其他机构转院(30.2% vs 10.2%,OR 3.704,P=0.014)和缺乏初级保健提供者(66.7% vs 11.8%,OR 14.603,P<0.001)。
临床怎么用
- 作者认为改善CLTI患者在门诊环境中转诊至血管外科医生(先于需要紧急院际转院)以及通过初级保健提供者进行照护协调,可能有助于提高血管随访依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic limb-threatening ischemia (CLTI) is associated with high morbidity and mortality. As such, close follow-up is recommended to ensure patency of revascularization, limb viability, and optimization of cardiovascular risk factors. This study aimed to test the association between follow-up adherence and mortality, and to identify risk factors for nonadherence with recommended vascular follow-up. METHODS: All patients hospitalized from 2019 to 2023 with infrainguinal CLTI and at least 30 days of posthospitalization survival were included. Patients were stratified based on adherence with any outpatient vascular follow-up within 1 year defined as any outpatient visit conducted after the index hospitalization in which CLTI of the index limb was addressed. The primary endpoint was 1-year mortality and risk factors for follow-up nonadherence were assessed to identify targets for improvement. Multivariable models adjusted for other relevant contributors to mortality including age, clinical comorbidities, medical therapies, and anatomic/clinical limb severity among others. Additional sensitivity analyses were conducted using various definitions of follow-up adherence to enhance reliability of the findings. RESULTS: A total of 131 patients with a median age of 73 years were included. A majority had tissue loss (97, 74.1%), 118 (90.1%) underwent index revascularization and 13 (9.9%) received no intervention due to nonsalvageable disease or patient preference. The overall 1-year mortality rate was 19.8% and follow-up adherence was 83.2%. Nonadherence with vascular follow-up was associated with greater 1-year mortality (40.9% vs. 15.6%, odds ratio (OR) 6.67, P = 0.005), a finding which persisted when all definitions of follow-up were tested. Risk factors for follow-up nonadherence include transfer from another institution (30.2% vs. 10.2%, OR 3.704, P = 0.014) and lack of a primary care provider (66.7% vs. 11.8%, OR 14.603, P < 0.001). CONCLUSIONS: Nonadherence with vascular follow-up is associated with higher 1-year mortality among patients with CLTI. Improved referral of CLTI patients to a vascular surgeon in the outpatient setting before the need for urgent interhospital transfer as well as care coordination through a primary care provider may help improve adherence with vascular follow-up.
引用
- Bloch RA, Ellias SD, Caron E, et al. The Impact of Follow-Up on Mortality in Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2024. PMID: 39675698. doi:10.1016/j.avsg.2024.11.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。